Archive | Health Professionals

Emerging options for high-risk melanoma

An ongoing study is attempting to build on what researchers have learned in recent years regarding neoadjuvant approaches to immunotherapy for high-risk melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Garutti Examines Advantages of Neoadjuvant Approaches in Melanoma

The use of adjuvant therapies in melanoma could offer superior efficacy compared to what is currently provided by adjuvant therapies alone, with some preclinical data pointing to increased clinical benefit within this patient population, according to Mattia Garutti, MD.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Melanoma ‘calculator’ for skin cancer risk

Australians will now be able to determine their likelihood of developing melanoma in under a minute with a new lifetime risk ‘calculator’.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Dr. Long on the Rationale for the Phase 3 COMBI-i Trial in BRAF V600¬–Mutant Melanoma

Georgina Long, BSc, PhD, MBBS, FRACP, co-medical director, Melanoma Institute Australia (MIA), chair of Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, University of Sydney, discusses the rationale for the phase 3 COMBI-i trial in BRAF V600­–mutant melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports